| Overview |
| bs-15099R-PE-Cy5.5 |
| C20orf166 Polyclonal Antibody, PE-Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human C20orf166 |
| 21-117/117 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 128826 |
| Extracellular matrix |
| C20orf166; Chromosome 20 open reading frame 166; CT166_HUMAN; dJ353C17.1; RP3-353C17.2; Uncharacterized protein C20orf166. |
| Representing about 2% of human DNA, chromosome 20 consists of approximately 63 million bases and 600 genes. Chromosome 20 contains a region with numerous genes expressed in the epididymis, which are thought important for seminal production, and some viewed as potential targets for male contraception. The PRNP gene encoding the prion protein associated with spongiform encephalopathies, like Creutzfeldt-Jakob disease, is found on chromosome 20. Amyotrophic lateral sclerosis, spinal muscular atrophy, ring chromosome 20 epilepsy syndrome and Alagille syndrome are also associated with chromosome 20. The C20orf166 gene product has been provisionally designated C20orf166 pending further characterization. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz